Menezes, Gisela L. G.
Mann, Ritse M.
Meeuwis, Carla
Bisschops, Bob
Veltman, Jeroen
Lavin, Philip T.
van de Vijver, Marc J.
Pijnappel, Ruud M.
Funding for this research was provided by:
Seno Medical Instruments
Article History
Received: 29 November 2018
Revised: 10 April 2019
Accepted: 2 May 2019
First Online: 27 May 2019
Compliance with ethical standards
:
: The scientific guarantor of this publication is Prof. Dr. Ruud M. Pijnappel.
: The authors of this manuscript declare relationships with the following companies:P.T.L. works for Boston Biostatistics Research Foundation, which has a research contract with Seno Medical Instruments to provide study design and analysis services.G.L.G.M has an employment contract with Seno Medical Instruments to provide scientific support in writing protocols, scientific manuscripts, data analyses, and support with scientific study design. All study data was collected, and the trial was closed 1,5 years before the beginning of G.L.G.M contract with Seno.R.M.M declares the following grants <i>outside the submitted work</i>: grants and nonfinancial support from Siemens Healthiness, grants from Identification Solution Inc., grants from Bayer Healthcare, and Screenpoint Medical.The remaining authors of this manuscript declare no conflicts of interest.
: One of the authors (P.T.L) has significant statistical expertise and provided statistical advice and analyses for this manuscript.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained from all participating hospitals.
: Some study subjects or cohorts have been previously reported in <i>Radiology</i>:<i>Menezes GLG, Pijnappel RM, Meeuwis C et al (2018) Downgrading of breast masses suspicious for cancer by using optoacoustic breast imaging. Radiology 288:355–365.</i>
: • Prospective• Observational• Multicenter study